GLMD logo

Galmed Pharmaceuticals (GLMD) Free Cash Flow

Annual FCF

-$6.14 M
+$12.37 M+66.84%

31 December 2023

GLMD Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

-$1.06 M
-$47.00 K-4.62%

30 September 2024

GLMD Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

-$4.81 M
+$1.11 M+18.79%

30 September 2024

GLMD TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GLMD Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+66.8%+51.1%+48.1%
3 y3 years+76.7%+88.2%+85.8%
5 y5 years+32.7%+72.5%+63.5%

GLMD Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+81.3%-18.5%+88.2%at high+85.8%
5 y5 yearsat high+81.3%-18.5%+88.5%at high+85.8%
alltimeall time-141.9%+81.3%-537.1%+88.5%-954.6%+85.8%

Galmed Pharmaceuticals Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$1.06 M(+4.6%)
-$4.81 M(-18.8%)
June 2024
-
-$1.02 M(-44.4%)
-$5.92 M(-5.6%)
Mar 2024
-
-$1.83 M(+103.8%)
-$6.27 M(+2.2%)
Dec 2023
-$6.14 M(-66.8%)
-$898.00 K(-58.8%)
-$6.14 M(-33.8%)
Sept 2023
-
-$2.18 M(+59.3%)
-$9.26 M(-9.2%)
June 2023
-
-$1.37 M(-19.4%)
-$10.20 M(-30.8%)
Mar 2023
-
-$1.70 M(-57.9%)
-$14.75 M(-20.3%)
Dec 2022
-$18.50 M(-43.8%)
-$4.03 M(+29.3%)
-$18.50 M(-13.8%)
Sept 2022
-
-$3.11 M(-47.3%)
-$21.47 M(-21.5%)
June 2022
-
-$5.91 M(+8.5%)
-$27.34 M(-5.9%)
Mar 2022
-
-$5.45 M(-22.0%)
-$29.07 M(-11.7%)
Dec 2021
-$32.90 M(+25.0%)
-$6.99 M(-22.2%)
-$32.90 M(-2.5%)
Sept 2021
-
-$8.99 M(+17.7%)
-$33.76 M(+11.0%)
June 2021
-
-$7.64 M(-17.8%)
-$30.41 M(+4.8%)
Mar 2021
-
-$9.29 M(+18.3%)
-$29.03 M(+10.3%)
Dec 2020
-$26.33 M(+76.1%)
-$7.85 M(+39.3%)
-$26.33 M(+16.8%)
Sept 2020
-
-$5.63 M(-10.0%)
-$22.55 M(+8.5%)
June 2020
-
-$6.26 M(-5.0%)
-$20.79 M(+17.4%)
Mar 2020
-
-$6.59 M(+61.9%)
-$17.71 M(+18.5%)
Dec 2019
-$14.95 M(+64.0%)
-$4.07 M(+5.1%)
-$14.95 M(+13.5%)
Sept 2019
-
-$3.87 M(+21.7%)
-$13.17 M(+17.5%)
June 2019
-
-$3.18 M(-16.8%)
-$11.21 M(+18.3%)
Mar 2019
-
-$3.83 M(+67.2%)
-$9.47 M(+3.9%)
Dec 2018
-$9.11 M
-$2.29 M(+19.6%)
-$9.11 M(-2.1%)
DateAnnualQuarterlyTTM
Sept 2018
-
-$1.91 M(+32.2%)
-$9.31 M(-9.5%)
June 2018
-
-$1.45 M(-58.3%)
-$10.29 M(-11.7%)
Mar 2018
-
-$3.47 M(+39.4%)
-$11.66 M(-3.4%)
Dec 2017
-$12.08 M(-0.6%)
-$2.49 M(-14.2%)
-$12.08 M(-2.7%)
Sept 2017
-
-$2.90 M(+2.8%)
-$12.41 M(-2.5%)
June 2017
-
-$2.82 M(-27.4%)
-$12.73 M(-1.6%)
Mar 2017
-
-$3.88 M(+37.9%)
-$12.94 M(+6.5%)
Dec 2016
-$12.15 M(+40.7%)
-$2.81 M(-12.4%)
-$12.15 M(+5.1%)
Sept 2016
-
-$3.21 M(+6.2%)
-$11.56 M(+8.9%)
June 2016
-
-$3.03 M(-1.9%)
-$10.61 M(+12.1%)
Mar 2016
-
-$3.09 M(+38.7%)
-$9.46 M(+9.6%)
Dec 2015
-$8.63 M(-13.8%)
-$2.23 M(-1.8%)
-$8.63 M(-11.6%)
Sept 2015
-
-$2.27 M(+20.6%)
-$9.77 M(+2.2%)
June 2015
-
-$1.88 M(-16.7%)
-$9.55 M(-4.9%)
Mar 2015
-
-$2.26 M(-32.8%)
-$10.04 M(+0.3%)
Dec 2014
-$10.01 M(+294.6%)
-$3.36 M(+63.3%)
-$10.01 M(+32.2%)
Sept 2014
-
-$2.06 M(-13.2%)
-$7.57 M(+16.4%)
June 2014
-
-$2.37 M(+6.6%)
-$6.51 M(+51.2%)
Mar 2014
-
-$2.22 M(+141.2%)
-$4.30 M(+69.7%)
Dec 2013
-$2.54 M(-18.5%)
-$922.00 K(-7.1%)
-$2.54 M(+57.1%)
Sept 2013
-
-$992.00 K(+494.0%)
-$1.61 M(+159.2%)
June 2013
-
-$167.00 K(-63.4%)
-$623.00 K(+36.6%)
Mar 2013
-
-$456.00 K
-$456.00 K
Dec 2012
-$3.11 M
-
-

FAQ

  • What is Galmed Pharmaceuticals annual free cash flow?
  • What is the all time high annual FCF for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals annual FCF year-on-year change?
  • What is Galmed Pharmaceuticals quarterly free cash flow?
  • What is the all time high quarterly FCF for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals quarterly FCF year-on-year change?
  • What is Galmed Pharmaceuticals TTM free cash flow?
  • What is the all time high TTM FCF for Galmed Pharmaceuticals?
  • What is Galmed Pharmaceuticals TTM FCF year-on-year change?

What is Galmed Pharmaceuticals annual free cash flow?

The current annual FCF of GLMD is -$6.14 M

What is the all time high annual FCF for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high annual free cash flow is -$2.54 M

What is Galmed Pharmaceuticals annual FCF year-on-year change?

Over the past year, GLMD annual free cash flow has changed by +$12.37 M (+66.84%)

What is Galmed Pharmaceuticals quarterly free cash flow?

The current quarterly FCF of GLMD is -$1.06 M

What is the all time high quarterly FCF for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high quarterly free cash flow is -$167.00 K

What is Galmed Pharmaceuticals quarterly FCF year-on-year change?

Over the past year, GLMD quarterly free cash flow has changed by +$1.11 M (+51.13%)

What is Galmed Pharmaceuticals TTM free cash flow?

The current TTM FCF of GLMD is -$4.81 M

What is the all time high TTM FCF for Galmed Pharmaceuticals?

Galmed Pharmaceuticals all-time high TTM free cash flow is -$456.00 K

What is Galmed Pharmaceuticals TTM FCF year-on-year change?

Over the past year, GLMD TTM free cash flow has changed by +$4.46 M (+48.09%)